News List 2018-2020.03
2020.03
' Involvement of MCL1, c-myc, and cyclin D2 protein degradation in ponatinib-induced cytotoxicity against T315I(+) Ph+leukemia cells ', a collaboration project with Dr. Takashi Murate at Chubu University, has been accepted by the Biochemical and Biophysical Research Communications.
2020.01
'A Novel Cytological Model of B-Cell/Macrophage Biphenotypic Cell Hodgkin Lymphoma in Ganp-Transgenic Mice ', a collaboration project with Dr. Kuwahara at our University, has been published in the Cancers.
2020.01
We invited Dr. Seiji Okada from Kumamoto University, and hold a lecture for graduate students.We thank to students and doctors who gave us lots of discussion and comments.
2019.12
Motoshi Suzuki had a lecture 'Epigenetic regulation of genomic instability in lung cancer' for graduate students at Kumamoto University. Thanks to students and researchers who attended there.
2019.10
' Divergent lncRNA MYMLR regulates MYC by eliciting DNA looping and promoter-enhancer interaction ', has been published in the EMBO J.
2019.06
We invited Dr. Takashi Takahashi, the president of Aichi Cancer Center, who had a lecture to us.
2019.04
Dr. Limsirichaikul has arrived with Thailand snacks. Surprise! some are already gone. .She is going to stay for two months.
2019.03
'ROR1-CAVIN3 interaction required for caveolae-dependent endocytosis and pro-survival signaling in lung adenocarcinoma', has been accepted by the Oncogene .
2018.12.19
Suzuki joined a brain meeting at Niigata University. It was an 'experience' to hear topics in a totally different field.
2018.12.07
We had an invited lecture by Dr. Naoko Kamiya, with a title."the role of Helicobacter pylori in stomach cancer".
We had lots of audience and got active discussion.Thank you very much.
2018.12.05
'Clustered DNA double-strand break formation and the repair pathway following heavy-ion irradiation', has been accepted by the BJournal of Radiation Research.
2018.10.01
Suzuki attended a US symposium 'Fidelity, Mutation in Cancer', and made a presentation entitled 'DNA polymerase and lung cancer'.
2018.09.28
Shi attended Japanese Cancer Association Meeting 2018, and made a presentation entitled 'A metastasis protein CERS6 is regulated by miR-101 and a transcription factor YB1'.
2018.08.21
'Nectin1 expression is frequently decreased in gastric cancers', has been accepted by the Pathology International.
2018.08.13
We have remodeled the lab space. P2-level experiments such as those using lenti-virus are allowed.
2018.08.09
Visit to Fuji Pharma Valley Center for discussion.
We have conducted a collaboration project, with a hope to invent a novel anti-cancer drug for patients.
2018.07.09
Dr. Yasumasa Ishida,Nara Institute of Science and Technology, visited us and gave a lecture ‘PD-1 and cancer, discrimination between self and non-self’
2018.07.02
'BCL2 inhibitor ABT-199 and JNK inhibitor SP600125 exhibit synergistic cytotoxicity against imatinib-resistant Ph+ ALL cells', has been accepted by the Biochemistry and Biophysics Reports.
2018.06.19
Chika Aoyama (Research Assistant) has joined us.
2018.06.01
Dr. Limsirichaikul from Silpakorn Univ (Thailand) is going to stay with us for 2 months.
2018.05.30
'Analysis of programmed death-ligand 1 expression in primary normal human dermal fibroblasts after DNA damage', has been accepted by the Human Immunology.
2018.04.12
'Corynebacterium kroppenstedtii in granulomatous mastitis: Analysis of formalin-fixed, paraffin-embedded biopsy specimens by immunostaining using low-specificity bacterial antisera and
real-time polymerase chain reaction', has been accepted by the Pathology International.
Contact information
Phone:+81-562-93-2440
e-mail:motosuzu*fujita-hu.ac.jp(In case of e-mail, please change * to @)
Address:1-98, Denrakugakubo, Kutsukake-cho, Toyoake-city, Aichi, 470-1192,
Japan